Provided by Tiger Trade Technology Pte. Ltd.

JENSCARE-B

9.390
+0.0100.11%
Volume:67.60K
Turnover:637.91K
Market Cap:3.92B
PE:-21.63
High:9.600
Open:9.400
Low:9.250
Close:9.380
52wk High:11.980
52wk Low:3.380
Shares:417.17M
HK Float Shares:310.31M
Volume Ratio:0.25
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.434
ROE:-26.00%
ROA:-13.50%
PB:3.96
PE(LYR):-21.63
PS:256.93

Loading ...

JENSCARE-B (09877) Sets 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Discuss Final Dividend

Bulletin Express
·
Mar 16

JENSCARE-B (09877) Announces Monthly Return on Movements in Securities for February 2026

Bulletin Express
·
Mar 05

JENSCARE-B Shares Surge Over 8% Following New Zealand Regulatory Approval for Two Core Heart Valve Therapies

Stock News
·
Feb 26

Jenscare Scientific Co., Ltd. (9877) Receives New Zealand Approval for Ken-Valve and LuX-Valve Plus

Bulletin Express
·
Feb 26

JENSCARE-B (09877): Ken-Valve and LuX-Valve Plus Secure Registration Approval in New Zealand

Stock News
·
Feb 26

Jenscare wins New Zealand registration approval for Ken-Valve and LuX-Valve Plus

Reuters
·
Feb 26

Jenscare Scientific Co Ltd - Receives Nz Approval for Ken-Valve and Lux-Valve Plus

THOMSON REUTERS
·
Feb 26

Duckling Fund L.P. Acquires Additional 160,000 Shares of JENSCARE-B (09877) at HK$8 Per Share

Stock News
·
Feb 09

Jenscare Scientific Receives U.S. Regulatory Nod to Begin Human Trials of Heart Implant

MT Newswires Live
·
Feb 09

JENSCARE-B (09877): LuX-Valve Plus Pivotal Registration Clinical Trial Receives FDA Approval

Stock News
·
Feb 06

Jenscare Scientific Receives FDA Approval for Pivotal Trial of LuX-Valve Plus

Reuters
·
Feb 06

Jenscare Scientific - Lux-Valve Plus Receives FDA Ide Approval for Pivotal Trial

THOMSON REUTERS
·
Feb 06

Jenscare Scientific (09877) Announces January 2026 Monthly Return

Bulletin Express
·
Feb 05

Jenscare Scientific Forecasts 2025 Revenue of RMB90 Million to RMB92 Million

Reuters
·
Jan 26

JENSCARE-B (09877) Forecasts Annual Total Revenue of Approximately RMB 105 Million to RMB 110 Million

Stock News
·
Jan 26

Jenscare Scientific - Expected Result Due to Solid Revenue From Ken-Valve, Others in FY

THOMSON REUTERS
·
Jan 26

Jenscare Scientific - Expects Revenue of RMB90-92 Mln for 2025

THOMSON REUTERS
·
Jan 26

Jenscare Scientific Co. Ltd. Held Extraordinary General Meeting

Reuters
·
Dec 30, 2025

Jenscare Scientific Files for EU Approval of Medical Device

MT Newswires Live
·
Dec 29, 2025

JENSCARE-B (09877): JensClip Submits Application for CE Mark Registration

Stock News
·
Dec 29, 2025